Shintaro Saito
Overview
Explore the profile of Shintaro Saito including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
A case of exogenous ochronosis in a Japanese patient: Capillaroscopic findings and literature review
Asatori A, Saito S, Inoue Y, Uchiyama A, Endo Y, Shibusawa Y, et al.
J Dermatol
. 2024 Dec;
PMID: 39641474
No abstract available.
2.
Mori H, Wakabayashi H, Saito S, Nakajima K, Yoshida K, Hiromasa T, et al.
Sci Rep
. 2024 Aug;
14(1):18208.
PMID: 39107450
No abstract available.
3.
Mori H, Wakabayashi H, Saito S, Nakajima K, Yoshida K, Hiromasa T, et al.
Sci Rep
. 2024 Jun;
14(1):13828.
PMID: 38879654
This study aimed to compare tumor lesion detectability and diagnostic accuracy of whole-body magnetic resonance imaging (WB-MRI) and radioiodine-labeled meta-iodo-benzylguanidine (mIBG) imaging techniques in patients with metastatic pheochromocytoma and paraganglioma...
4.
Saito S, Nakajima K, Komatsu J, Shibutani T, Wakabayashi H, Mori H, et al.
EJNMMI Rep
. 2024 May;
8(1):15.
PMID: 38822219
Background And Purpose: The ability of [I]metaiodobenzylguanidine (MIBG) sympathetic nerve imaging with three-dimensional (3D) quantitation to clinically diagnose neurological disorders has not been evaluated. This study compared absolute heart counts...
5.
Saito S, Nakajima K, Shibutani T, Wakabayashi H, Yoneyama H, Konishi T, et al.
Ann Nucl Cardiol
. 2023 Dec;
9(1):61-67.
PMID: 38058582
: A three-dimensional (3D) approach to absolute quantitation of I-metaiodobenzylguanidine (MIBG) sympathetic nerve imaging using single-photon emission tomography (SPECT) / computed tomography (CT) is not available. Therefore, we calculated absolute...
6.
Mori T, Namikawa K, Yamazaki N, Kiniwa Y, Yamasaki O, Yoshikawa S, et al.
Front Med (Lausanne)
. 2023 Aug;
10:1229937.
PMID: 37636577
Background: Anti-programmed cell death protein 1 (PD-1) monotherapy is one of the standard systemic therapies for advanced melanoma; however, the efficacy of salvage systemic therapies after PD-1 monotherapy failure (PD-1...
7.
Doi R, Baba N, Kato H, Nakamura M, Matsushita S, Aoki M, et al.
Exp Dermatol
. 2023 Jul;
32(10):1682-1693.
PMID: 37395158
Japanese patients with very high-risk cutaneous squamous cell carcinomas (cSCCs), based on the National Comprehensive Cancer Network guidelines, have been reported to display a higher cumulative incidence of relapse and...
8.
Kuriyama Y, Yasuda M, Saito S, Nakano H, Shimizu A, Tamura A, et al.
J Dermatol
. 2023 May;
50(10):e325-e326.
PMID: 37183530
No abstract available.
9.
Kosaka K, Yasuda M, Kim J, Saito S, Uehara A, Handa H, et al.
J Dermatol
. 2022 Dec;
50(5):e171-e172.
PMID: 36585760
No abstract available.
10.
Akatani N, Wakabayashi H, Kayano D, Inaki A, Takata A, Hiromasa T, et al.
Endocr J
. 2022 Dec;
70(3):315-322.
PMID: 36567077
Long-term survival in patients with differentiated thyroid cancer (DTC) and lung metastasis remains unexplored in Japan. This study aimed to investigate the long-term survival and prognostic factors of radioiodine therapy...